STOCK TITAN
  1. Home
  2. News
  3. A

Agilent Technologies Inc. - A STOCK NEWS

Welcome to our dedicated news page for Agilent Technologies (Ticker: A), a resource for investors and traders seeking the latest updates and insights on Agilent Technologies.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Agilent Technologies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Agilent Technologies's position in the market.

News
Agilent Announces Cash Dividend of 23.6 Cents per Share
Rhea-AI Summary
Agilent Technologies Inc. (A) declares a quarterly dividend of 23.6 cents per share of common stock, payable on April 24, 2024, to shareholders of record as of April 2, 2024, subject to board approval.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.45%
Tags
dividends
-
News
Agilent CEO Mike McMullen to Retire; Agilent CrossLab Group President Padraig McDonnell Named CEO-Elect
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) announces Padraig McDonnell as CEO-elect and COO, succeeding current CEO Mike McMullen. McDonnell, with nearly 40 years of experience, will take over on May 1, with McMullen retiring on Oct. 31. The transition reflects Agilent's strong leadership and succession planning.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.45%
Tags
none
-
News
Agilent Ranked Among Top 50 Most Just Companies in America
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) has been recognized as one of the Most JUST Companies in America by Just Capital and CNBC for the sixth consecutive year. The company has consistently ranked in the top 50, showcasing its commitment to business issues important to the public, such as fair wages, job creation, and stakeholder accountability. Agilent's focus on ESG programs and community prosperity has earned it this prestigious recognition.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.93%
Tags
none
News
Agilent Wins Two Scientists’ Choice Awards for Drug Discovery and Development Products
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) has received two prestigious awards from SelectScience for Best New Drug Discovery & Development Product of 2023 and Drug Discovery & Development Webinar of the Year. The awards highlight Agilent's commitment to innovation and excellence in drug discovery and development. The Agilent xCELLigence RTCA HT-BioTek BioSpa 8 - Screening Model won the Best New Drug Discovery & Development Product of 2023. The Drug Discovery & Development Webinar of the Year was co-produced between Agilent and Dr. Agapitos Patakas, Chief Scientific Officer, Antibody Analytics. The awards were presented at the 2024 SLAS International Conference and Exhibition in Boston, Massachusetts, and recognize innovative and effective technologies advancing drug discovery and development in 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.96%
Tags
none
-
News
Agilent to Participate in TD Cowen Health Care Conference
Rhea-AI Summary
Agilent Technologies Inc. (A) CFO Bob McMahon to participate in fireside chat at the 44th Annual TD Cowen Health Care Conference. The event will take place in Boston, Massachusetts, on March 4, at 2:50 p.m. EST. A live audio webcast and replay of the presentation will be available on the Agilent Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.26%
Tags
conferences
-
News
Agilent Announces Collaboration with Incyte to Develop Advanced Companion Diagnostics in Hematology and Oncology
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) has announced a partnership with Incyte to develop companion diagnostics (CDx) for Incyte’s hematology and oncology portfolio. The companion diagnostics market is expected to grow to nearly US $14B by 2030, driven by the increasing use of these tests to inform treatment decisions for a variety of cancers and chronic diseases. The collaboration will allow Agilent to expand its CDx portfolio with novel biomarkers, while leveraging Incyte’s expertise in IVD assay development and global regulatory approvals. The partnership aims to expedite the development of precision medicine products, potentially improving patient health outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.09%
Tags
none
News
Agilent to Announce First-Quarter Fiscal Year 2024 Financial Results Feb. 27
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) is set to release its financial results for the first quarter of fiscal year 2024, with the conference call scheduled to discuss the results. The call will be available for 90 days on the company's investor relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.08%
Tags
earnings
-
News
Agilent Announces New ProteoAnalyzer System
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) has announced the release of a new automated parallel capillary electrophoresis system for protein analysis, the Agilent ProteoAnalyzer system. The new platform simplifies and improves the efficiency of analyzing complex protein mixtures, benefiting diverse sectors from pharma to academia. The system brings added efficiency, versatility, and reliability, particularly in protein QC workflows. It can analyze different sizes and types of proteins in a single run and consistently deliver accurate results, reducing the need for time-consuming and costly reanalysis.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.01%
Tags
none
-
News
Agilent Named to Dow Jones Sustainability Indices for Ninth Consecutive Year
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) has been included in the Dow Jones Sustainability World Index and the North America Index for its strong environmental, social, and governance (ESG) performance. The company has been named in the Dow Jones Sustainability Indices for a ninth consecutive year, with only 3,500 of the largest companies globally eligible for inclusion. Agilent's sustainability performance was scored 'very high' on the S&P Global's annual Corporate Sustainability Assessment (CSA), far above the industry average in all three categories. The company is named in both the Dow Jones Sustainability World Index and the Dow Jones Sustainability North America Index, marking the ninth year of its inclusion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.34%
Tags
none
News
Agilent Makes Strategic Updates to Organizational Structure
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) has moved its Cell Analysis Division into its Diagnostics and Genomics Group (DGG) to strengthen growth opportunities. This strategic move aims to align with customer needs and expand workflow coverage for accelerated growth. The company's cell analysis work, driven by acquisitions of BioTek Instruments, ACEA Biosciences, and Seahorse Bioscience, has been a significant growth driver. Agilent will report under the new structure starting from the first quarter fiscal 2024 results and will recast historical segment information accordingly.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.15%
Tags
none
Stock A logo
Agilent Technologies Inc.

NYSE:A

A Rankings

#315 Ranked by Market Cap
#3641 Ranked by Stock Gains
#1934 Ranked by Dividends

A Stock Data

40.09B
291.94M
0.28%
93.13%
1.35%
Analytical Laboratory Instrument Manufacturing
Manufacturing
Link
US
Santa Clara

About A

analytical scientists and clinical researchers worldwide rely on agilent to help fulfill their most complex laboratory demands. our instruments, software, services and consumables address the full range of scientific and laboratory management needs—so our customers can do what they do best: improve the world around us. whether a laboratory is engaged in environmental testing, academic research, medical diagnostics, pharmaceuticals, petrochemicals or food testing, agilent provides laboratory solutions to meet their full spectrum of needs. we work closely with customers to help address global trends that impact human health and the environment, and to anticipate future scientific needs. our solutions improve the efficiency of the entire laboratory, from sample prep to data interpretation and management. customers trust agilent for solutions that enable insights...for a better world.